Opaleye Management Inc. Buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics ...

GuruFocus.com2021-12-21

Cambridge, MA, based Investment company Opaleye Management Inc. ( Current Portfolio) buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics Pharmaceuticals Inc, Amicus Therapeutics Inc, Merus ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2193785157?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-12-21 22:38","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2193785157","market":"us","top_or_hot":-1,"title":"Opaleye Management Inc. Buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics ...","media":"GuruFocus.com","content":"<div>\n<p>Cambridge, MA, based Investment company \nOpaleye Management Inc. (\nCurrent Portfolio) buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics Pharmaceuticals Inc, Amicus Therapeutics Inc, Merus ...</p>\n\n<a href=\"https://finance.yahoo.com/news/opaleye-management-inc-buys-semler-143803654.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Opaleye Management Inc. Buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics ...</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOpaleye Management Inc. Buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics ...\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-21 22:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/opaleye-management-inc-buys-semler-143803654.html><strong>GuruFocus.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cambridge, MA, based Investment company \nOpaleye Management Inc. (\nCurrent Portfolio) buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics Pharmaceuticals Inc, Amicus Therapeutics Inc, Merus ...</p>\n\n<a href=\"https://finance.yahoo.com/news/opaleye-management-inc-buys-semler-143803654.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://finance.yahoo.com/news/opaleye-management-inc-buys-semler-143803654.html","article_id":"2193785157","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2193785157","pubTimestamp":1640097483,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Cambridge, MA, based Investment company \nOpaleye Management Inc. (\nCurrent Portfolio) buys Semler Sc","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","CRCT":"Cricut, Inc.","MGNX":"MacroGenics Inc.","OLPX":"Olaplex Holdings, Inc.","MRUS":"Merus B.V.","LUMO":"Lumos Pharma Inc.","CRNX":"Crinetics Pharmaceuticals Inc.","BK4167":"医疗保健技术","KZR":"Kezar Life Sciences Inc.","HCTI":"Healthcare Triangle, Inc.","NCNA":"Nucana PLC","FOLD":"爱美医疗","AADI":"Aadi Biosciences, Inc.","SIOX":"Sio Gene Therapies Inc.","CRDF":"Cardiff Oncology, Inc.","TERN":"Terns Pharmaceuticals, Inc.","BK4209":"餐馆","SRU.SI":"CSOP iEdge SREIT ETF US$","SMLR":"Semler Scientific, Inc.","BK4183":"个人用品","FWRG":"First Watch Restaurant Group, Inc.","KROS":"Keros Therapeutics, Inc.","AVEO":"AVEO制药公司","EPIX":"ESSA Pharma Inc.","BK4539":"次新股","OPTN":"Optinose Inc.","APTO":"Aptose Biosciences Inc","BK4191":"家用电器","DTIL":"Precision Biosciences Inc","MCRB":"Seres Therapeutics, Inc."},"translate_title":"Opaleye管理公司收购Semler科学公司、Keros治疗公司、Crinetics...","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ALVU":1,"TERN":1,"OLPX":1,"HCTI":1,"FWRG":1,"CRCT":1,"OPTN":0.9,"KROS":0.6,"AADI":0.6,"SRU.SI":0.6,"SMLR":0.6,"SIOX":0.6,"APTO":0.6,"NCNA":0.6,"MRUS":0.6,"MGNX":0.6,"MCRB":0.6,"LUMO":0.6,"KZR":0.6,"AVEO":0.6,"FOLD":0.6,"EPIX":0.6,"DTIL":0.6,"CRNX":0.6,"CRDF":0.6},"content_text":"Cambridge, MA, based Investment company \nOpaleye Management Inc. (\nCurrent Portfolio) buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics Pharmaceuticals Inc, Amicus Therapeutics Inc, Merus NV, sells ESSA Pharma Inc, Seres Therapeutics Inc, CM Life Sciences Inc, Lumos Pharma Inc, Kezar Life Sciences Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Opaleye Management Inc.. As of 2021Q3, Opaleye Management Inc. owns 48 stocks with a total value of $535 million. These are the details of the buys and sells.\n\n\nNew Purchases: SMLR, FOLD, MRUS, DTIL, AADI, NCNA, AKBA, CBAY, SELB, \nAdded Positions: KROS, CRNX, CMRX, KNSA, HROW, LRMR, OPTN, STRO, PRQR, FMTX, \nReduced Positions: ETON, MGNX, SIOX, APTO, AVEO, ADMS, NLTX, FBIO, AVTX, BBIO, XOMA, AFIB, LPTX, PCVX, \nSold Out: EPIX, MCRB, CMLF, LUMO, KZR, CRDF, PHVS, CFRX, CDTX, \n\n\nKROS 15-Year Financial Data\nThe intrinsic value of KROS\nPeter Lynch Chart of KROS\n\n\nFor the details of Opaleye Management Inc.'s stock buys and sells,go to https://www.gurufocus.com/guru/opaleye+management+inc./current-portfolio/portfolio\nThese are the top 5 holdings of Opaleye Management Inc.\n\nOcular Therapeutix Inc (OCUL) - 6,480,000 shares, 12.10% of the total portfolio. \nCelldex Therapeutics Inc (CLDX) - 985,000 shares, 9.91% of the total portfolio. \nCodexis Inc (CDXS) - 1,345,000 shares, 5.84% of the total portfolio. \nChimerix Inc (CMRX) - 5,030,000 shares, 5.82% of the total portfolio. Shares added by 8.64%\nHarrow Health Inc (HROW) - 3,285,000 shares, 5.58% of the total portfolio. Shares added by 4.62%\n\nNew Purchase: Semler Scientific Inc (SMLR)\n\n\nOpaleye Management Inc. initiated holding in Semler Scientific Inc. The purchase prices were between $106 and $129, with an estimated average price of $114.25. The stock is now traded at around $93.220000. The impact to a portfolio due to this purchase was 5.27%. The holding were 225,566 shares as of 2021-09-30. \nNew Purchase: Amicus Therapeutics Inc (FOLD)\n\n\nOpaleye Management Inc. initiated holding in Amicus Therapeutics Inc. The purchase prices were between $8.74 and $11.84, with an estimated average price of $10.24. The stock is now traded at around $11.230000. The impact to a portfolio due to this purchase was 0.57%. The holding were 320,800 shares as of 2021-09-30. \nNew Purchase: Merus NV (MRUS)\n\n\nOpaleye Management Inc. initiated holding in Merus NV. The purchase prices were between $16.48 and $27.23, with an estimated average price of $21.52. The stock is now traded at around $29.870000. The impact to a portfolio due to this purchase was 0.41%. The holding were 100,250 shares as of 2021-09-30. \nNew Purchase: Precision BioSciences Inc (DTIL)\n\n\nOpaleye Management Inc. initiated holding in Precision BioSciences Inc. The purchase prices were between $9.18 and $14.15, with an estimated average price of $11.34. The stock is now traded at around $8.180000. The impact to a portfolio due to this purchase was 0.35%. The holding were 163,900 shares as of 2021-09-30. \nNew Purchase: Aadi Bioscience Inc (AADI)\n\n\nOpaleye Management Inc. initiated holding in Aadi Bioscience Inc. The purchase prices were between $0 and $32.66, with an estimated average price of $27.53. The stock is now traded at around $25.820000. The impact to a portfolio due to this purchase was 0.25%. The holding were 45,020 shares as of 2021-09-30. \nNew Purchase: NuCana PLC (NCNA)\n\n\nOpaleye Management Inc. initiated holding in NuCana PLC. The purchase prices were between $1.95 and $2.85, with an estimated average price of $2.37. The stock is now traded at around $2.340000. The impact to a portfolio due to this purchase was 0.23%. The holding were 479,600 shares as of 2021-09-30. \nAdded: Keros Therapeutics Inc (KROS)\n\nOpaleye Management Inc. added to a holding in Keros Therapeutics Inc by 50.00%. The purchase prices were between $29.27 and $43.71, with an estimated average price of $35.63. The stock is now traded at around $52.930000. The impact to a portfolio due to this purchase was 0.87%. The holding were 352,500 shares as of 2021-09-30. \nAdded: Crinetics Pharmaceuticals Inc (CRNX)\n\nOpaleye Management Inc. added to a holding in Crinetics Pharmaceuticals Inc by 100.56%. The purchase prices were between $16.88 and $25.23, with an estimated average price of $20.96. The stock is now traded at around $25.270000. The impact to a portfolio due to this purchase was 0.79%. The holding were 402,113 shares as of 2021-09-30. \nAdded: OptiNose Inc (OPTN)\n\nOpaleye Management Inc. added to a holding in OptiNose Inc by 27.06%. The purchase prices were between $2.35 and $3.16, with an estimated average price of $2.8. The stock is now traded at around $1.700000. The impact to a portfolio due to this purchase was 0.19%. The holding were 1,558,500 shares as of 2021-09-30. \nSold Out: ESSA Pharma Inc (EPIX)\n\nOpaleye Management Inc. sold out a holding in ESSA Pharma Inc. The sale prices were between $7.76 and $29.37, with an estimated average price of $15.99. \nSold Out: Seres Therapeutics Inc (MCRB)\n\nOpaleye Management Inc. sold out a holding in Seres Therapeutics Inc. The sale prices were between $5.46 and $22.6, with an estimated average price of $9.91. \nSold Out: CM Life Sciences Inc (CMLF)\n\nOpaleye Management Inc. sold out a holding in CM Life Sciences Inc. The sale prices were between $11.39 and $13.99, with an estimated average price of $12.54. \nSold Out: Lumos Pharma Inc (LUMO)\n\nOpaleye Management Inc. sold out a holding in Lumos Pharma Inc. The sale prices were between $7.36 and $11.36, with an estimated average price of $9.43. \nSold Out: Kezar Life Sciences Inc (KZR)\n\nOpaleye Management Inc. sold out a holding in Kezar Life Sciences Inc. The sale prices were between $4.85 and $9.73, with an estimated average price of $6.63. \nSold Out: Cardiff Oncology Inc (CRDF)\n\nOpaleye Management Inc. sold out a holding in Cardiff Oncology Inc. The sale prices were between $5.01 and $7.58, with an estimated average price of $6.31. \nReduced: Macrogenics Inc (MGNX)\n\nOpaleye Management Inc. reduced to a holding in Macrogenics Inc by 20.09%. The sale prices were between $19.74 and $28.7, with an estimated average price of $24.13. The stock is now traded at around $17.140000. The impact to a portfolio due to this sale was -0.52%. Opaleye Management Inc. still held 462,000 shares as of 2021-09-30.\nReduced: Sio Gene Therapies Inc (SIOX)\n\nOpaleye Management Inc. reduced to a holding in Sio Gene Therapies Inc by 52.25%. The sale prices were between $1.81 and $2.7, with an estimated average price of $2.18. The stock is now traded at around $1.380000. The impact to a portfolio due to this sale was -0.45%. Opaleye Management Inc. still held 955,000 shares as of 2021-09-30.\nReduced: Aptose Biosciences Inc (APTO)\n\nOpaleye Management Inc. reduced to a holding in Aptose Biosciences Inc by 43.98%. The sale prices were between $2.18 and $3.41, with an estimated average price of $2.79. The stock is now traded at around $1.390000. The impact to a portfolio due to this sale was -0.24%. Opaleye Management Inc. still held 549,000 shares as of 2021-09-30.\nReduced: AVEO Pharmaceuticals Inc (AVEO)\n\nOpaleye Management Inc. reduced to a holding in AVEO Pharmaceuticals Inc by 29.58%. The sale prices were between $5.12 and $6.89, with an estimated average price of $5.99. The stock is now traded at around $5.010000. The impact to a portfolio due to this sale was -0.21%. Opaleye Management Inc. still held 455,600 shares as of 2021-09-30.\n\nHere is the complete portfolio of Opaleye Management Inc.. Also check out:\n\n1. Opaleye Management Inc.'s Undervalued Stocks\n\n2. Opaleye Management Inc.'s Top Growth Companies, and\n\n3. Opaleye Management Inc.'s High Yield stocks\n\n4. Stocks that Opaleye Management Inc. keeps buyingThis article first appeared on \nGuruFocus.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2193785157"}